Follow
Dhiraj Kumar
Title
Cited by
Cited by
Year
Rapid PD-L1 detection in tumors with PET using a highly specific peptide
S Chatterjee, WG Lesniak, MS Miller, A Lisok, E Sikorska, B Wharram, ...
Biochemical and biophysical research communications 483 (1), 258-263, 2017
1652017
Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
ADR Silva, D Kumar, A Lisok, S Chatterjee, B Wharram, VK Rao, R Mease, ...
Molecular Pharmaceuticals 15 (9), 3946-3952, 2018
1142018
Peptide-based PET quantifies target engagement of PD-L1 therapeutics
D Kumar, A Lisok, E Dahmane, M McCoy, S Shelake, S Chatterjee, V Allaj, ...
The Journal of Clinical Investigation 129 (2), 616-630, 2019
1102019
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
WG Lesniak, RC Mease, S Chatterjee, D Kumar, A Lisok, B Wharram, ...
Molecular imaging 18, 1536012119852189, 2019
602019
The Thiophene “Sigma-Hole” as a Concept for Preorganized, Specific Recognition of G⋅C Base Pairs in the DNA Minor Groove
WDW Pu Guo, Ananya Paul, Arvind Kumar, Abdelbasset A. Farahat, Dhiraj Kumar ...
Chemistry-A European Journal 22, 15404-15412, 2016
372016
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics
D Kumar, A Mishra, A Lisok, R Kureshi, S Shelake, D Plyku, R Sen, ...
PNAS 118 (37), 1-12, 2021
262021
Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer
L Chen, C Long, J Nguyen, D Kumar, J Lee
Bioorganic & Medicinal Chemistry Letters 28 (3), 420-424, 2018
122018
Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics
A Mishra, D Kumar, K Gupta, G Lofland, AK Sharma, DS Banka, ...
Clinical Cancer Research, 2023
102023
Stereo controlled oxyselenation studies on 1,4-dihydropyridines: Synthesis of trans-2-hydroxy- or 2-alkoxy-3-phenylseleno-1,2,3,4-tetrahydropyridines
R Kumar, D Kumar, AK Prasad
Synthetic Communications 41 (17), 2640–2648, 2011
62011
Characterization of chimeric antigen receptor modified T cells expressing scFv‑IL‑13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging
P Leland, D Kumar, S Nimmagadda, S Bauer, R Puri, B Joshi
Journal of Translational Medicine 21 (367), 2023
32023
Oxidative Additions with 1,4-Dihydropyridines: A One-Pot Synthesis of 3,4,4a,5,8,8a-Hexahydro-2H-pyrido[3,2-b][1,4]oxazine Derivatives
R Kumar, S Malik, D Kumar, AK Prasad
Synthetic Communications 41 (18), 2719-2726, 2011
22011
Non-Invasive PD-L1 Quantification Using [18F]DK222-PET Imaging In Cancer Immunotherapy
SN Akhilesh Mishra, Kuldeep Gupta, Dhiraj Kumar, Gabriela Lofland, Ajay ...
Journal of ImmunoTherapy of Cancer 11 (10), 2023
12023
Facile synthesis of autophagonizer and evaluation of its activity to induce autophagic cell death in apoptosis-defective cell line
J Nguyen, L Chen, D Kumar, J Lee
Bioorganic & Medicinal Chemistry Letters 26 (19), 4753-4756, 2016
12016
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1
S Ludwig, B Meksiriporn, J Tan, R Kureshi, A Mishra, K Kaeo, A Zhu, ...
Cell Chemical Biology 31, 1-16, 2024
2024
CD38-Specific Gallium-68 Labeled Peptide RadiotracerEnables Pharmacodynamic Monitoring in Multiple Myelomawith PET
SN Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Ian ...
Advanced Science, 1-13, 2024
2024
Tumor and immune cell imaging based on PD-L1 expression
S Nimmagadda, M Pomper, S Chatterjee, W Lesniak, D Kumar
US Patent 11,607,466, 2023
2023
An optimized radiosynthesis of [18F]DK222, a PET radiotracer for imaging PD-L1
RFD Daniel P. Holt, Dhiraj Kumar, Sridhar Nimmagadda
Journal of labelled Compounds and Radiopharmaceuticals, 2023
2023
Synthesis, Antimicrobial Screening and Docking Studies of Newer 1,4-Dihydropyridine tethered Chalcone Hybrids
LK Rakesh Kumar, Dhiraj Kumar, Ravindra Kumar Upadhyay, Nidhi Deswal, Priya ...
Chemistry Select, 2022
2022
Non-invasive quantification of pharmacodynamic effects of an antibody targeting PSMA by PET imaging
SN Akhilesh Mishra, Zora Nováková, Ala Lisok, Dhiraj Kumar, Ronnie C Mease ...
American Association for Cancer Research 80 (16 Supplement), 2779-2779, 2020
2020
A highly specific 18F-labelled peptide for non-invasive quantification of PD-L1 levels in tumors
SN D Kumar, A Mishra, A Lisok, S Shelake, B Wharram, R Desilva, R Mease
American Association for Cancer Research 80 (16 Supplement), 3448-3448, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20